Episodes 1-15 of 669
Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
Project Oncology®Giredestrant and Everolimus in HR+/HER2- Breast Cancer: Insights from evERA
SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
Project Oncology®SERENA-6: Assessing Camizestrant’s Impact in HR+/HER2- Breast Cancer
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Project Oncology®Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Project Oncology®Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Project Oncology®Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
- advertisement
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Project Oncology®Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
The Future of Immunotherapy: Advancing Care in Endometrial Cancer
Project Oncology®The Future of Immunotherapy: Advancing Care in Endometrial Cancer
Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Project Oncology®Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Early Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
Project Oncology®Early Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
Heart MattersRethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
Project Oncology®10-Year PORTEC-3 Outcomes: Chemoradiotherapy in High-Risk Endometrial Cancer
- advertisement
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Project Oncology®Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Real-World CDK4/6 Inhibitor Patterns in HR+/HER2– Metastatic Breast Cancer
Project Oncology®Real-World CDK4/6 Inhibitor Patterns in HR+/HER2– Metastatic Breast Cancer
Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
Project Oncology®Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
